| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/06/2011 | CN102007130A Antibiotic tetrahydro-beta-carboline derivatives |
| 04/06/2011 | CN102007125A Fused heterocyclic derivatives and methods of use |
| 04/06/2011 | CN102007124A Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 04/06/2011 | CN102002048A Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 04/06/2011 | CN102002047A Phthalocyanine compound and organic thin film transistor |
| 04/06/2011 | CN102002046A Organic light emitting device |
| 04/06/2011 | CN102002045A Pyrazolopyrimidinone derivatives as well as preparation method and application thereof |
| 04/06/2011 | CN102001904A Novel chiral separation method |
| 04/06/2011 | CN102000602A Cyclamine catalyst |
| 04/05/2011 | US7919621 Tricyclic inhibitors of 5-lipoxygenase |
| 04/05/2011 | US7919615 Route to formyl-porphyrins |
| 04/05/2011 | US7919528 Antibiotic; bactericides |
| 04/05/2011 | US7919498 Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors |
| 04/05/2011 | US7919491 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 04/05/2011 | CA2574822C Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 04/05/2011 | CA2569850C 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer |
| 04/05/2011 | CA2515730C Pyrrolidinohydrochinazolines |
| 04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 03/31/2011 | WO2011038283A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/31/2011 | WO2011038185A2 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| 03/31/2011 | WO2011036576A1 Gpr 119 modulators |
| 03/31/2011 | WO2011036566A1 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| 03/31/2011 | WO2011036505A1 New 6-substituted pyrimidine derivatives |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011036127A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors |
| 03/31/2011 | WO2011035725A1 Sitagliptin intermediates, preparation methods and uses thereof |
| 03/31/2011 | WO2011035518A1 Pyrimidine derivatives and analogs, preparation method and use thereof |
| 03/31/2011 | WO2011035417A1 Hsp-90 binding compounds, compositions thereof, and their use fn the treatment of autoimmune and inflammatory diseases |
| 03/31/2011 | WO2011017299A3 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
| 03/31/2011 | WO2011012698A3 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 03/31/2011 | WO2011002808A8 Hcv protease inhibitors and uses thereof |
| 03/31/2011 | WO2010151740A3 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases |
| 03/31/2011 | WO2010129656A3 Method of oligonucleotide labeling using cycloaddition reaction |
| 03/31/2011 | WO2010120112A3 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof |
| 03/31/2011 | WO2010111381A3 Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one |
| 03/31/2011 | WO2010096170A3 Inhibition of trna synthetases and therapeutic applications thereof |
| 03/31/2011 | WO2010066629A3 Novel azaindoles |
| 03/31/2011 | US20110077401 Anti-angiogenic compounds |
| 03/31/2011 | US20110077395 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 03/31/2011 | US20110077394 Light-driven rotary molecular motors |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/31/2011 | US20110077235 Apoptosis signal-regulating kinase 1 inhibitors |
| 03/31/2011 | US20110076598 Corrin compound fuel cell catalysts |
| 03/31/2011 | US20110076214 Reversible Room-Temperature Ionic Liquids |
| 03/31/2011 | CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
| 03/31/2011 | CA2774387A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/31/2011 | CA2773827A1 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| 03/31/2011 | CA2773742A1 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| 03/31/2011 | CA2772188A1 Gpr 119 modulators |
| 03/31/2011 | CA2770087A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 1oa inhibitors |
| 03/30/2011 | EP2301939A1 Enzyme inhibitors |
| 03/30/2011 | EP2301938A1 Crystalline of eszopiclone, its composition, preparation and uses thereof |
| 03/30/2011 | EP2301936A1 Spirodiamine-diarylketoxime derivative |
| 03/30/2011 | EP2301926A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound |
| 03/30/2011 | EP2301921A1 Polycyclic compound and organic electroluminescent device using the same |
| 03/30/2011 | EP2301909A1 Processes for preparing pemetrexed disodium and its intermediate,4-(4-carbomethoxyphenyl)butanal |
| 03/30/2011 | EP2300478A1 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators |
| 03/30/2011 | EP2300469A2 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 03/30/2011 | EP2300455A2 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl) - imidazo [1, 2-b] [1, 2, 4] triazin-2-yl] benzamide and processes related to preparing the same |
| 03/30/2011 | EP2300436A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
| 03/30/2011 | EP2300435A2 Heterocyclic compounds as factor ixa inhibitors |
| 03/30/2011 | EP2300430A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/30/2011 | EP2300422A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 03/30/2011 | EP2299821A1 Novel tricyclic compounds |
| 03/30/2011 | EP2299816A1 Inhibitors of janus kinases |
| 03/30/2011 | EP2176259B1 Fused imidazoles for cancer treatment |
| 03/30/2011 | EP2081934B1 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound |
| 03/30/2011 | EP2057125B1 Non-nucleoside reverse transcriptase inhibitors |
| 03/30/2011 | EP1937687B1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE |
| 03/30/2011 | EP1636237B1 Treatment of high performance pigments with etheramine dispersing salts |
| 03/30/2011 | EP1558586B1 Inhibitors of akt activity |
| 03/30/2011 | EP1277738B1 Condensed heteroaryl derivatives |
| 03/30/2011 | CN101993445A Organic light-emitting device |
| 03/30/2011 | CN101993415A Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof |
| 03/30/2011 | CN101993409A Heterocyclic compound, organic light-emitting device containing polycyclic heteroaryl compounds |
| 03/30/2011 | CN101993385A Method for recycling urotropine and glycine by utilizing macroporous absorption resin |
| 03/29/2011 | US7915408 Triazolotriazines as kinase inhibitors |
| 03/29/2011 | US7915404 Methods for the preparation of pyrazole-containing compounds |
| 03/29/2011 | US7915300 Cysteine protease inhibitors |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915266 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents |
| 03/29/2011 | US7915260 Urotensin II receptor antagonists |
| 03/29/2011 | US7915258 Substituted 2,5-dihydro-3H-pyrazolo[4,3-C]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same |
| 03/29/2011 | US7915251 Alpha-helix mimetics and methods relating to the treatment of fibrosis |
| 03/29/2011 | US7914706 Charge transport compositions and electronic devices made with such compositions |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2465326C Pyrazolopyrimidines for decreasing ion flow through a voltage-dependent sodium channel |
| 03/29/2011 | CA2452845C Dye-sulfenates for dual phototherapy |
| 03/29/2011 | CA2428223C Compounds and methods for promoting smoking cessation |
| 03/29/2011 | CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof |
| 03/24/2011 | WO2011035231A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 03/24/2011 | WO2011035139A1 Process for preparing azabicyclic compounds |
| 03/24/2011 | WO2011034183A1 Porphyrin compound |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011033055A1 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | WO2011033053A1 Macrocyclic inhibitors of jak |
| 03/24/2011 | WO2011032692A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| 03/24/2011 | WO2010129864A3 Methods and compositions for studying, imaging, and treating pain |
| 03/24/2011 | WO2010117787A3 Inhibiting eph b-3 kinase |
| 03/24/2011 | US20110071288 Intermediate useful in preparing certain pyrrolotriazine compounds and a process for making the intermediate |